EGFR and hepatocellular carcinoma: Moreover, in triple-negative BC cell lines (MDA-MB-231, MDA-MB-468, and HCC-1806), a crosstalk between LEP and IGF-1 signaling has been demonstrated to promote the transactivation of the epidermal growth factor receptor (EGFR), which may enhance tumor cell invasion and migration [47].